The Rise of the “Fractional Specialist”: Why Legal Teams Are Quietly Rewriting Their Hiring Playbook
By: Daniel Santos, Special Counsel | May 29, 2026 Daniel Santos Helping Healthtech CEOs &…
The New Board Question: “What’s Our Exposure to AI‑Driven Misconduct?”
Two companies, same AI tools, totally different risk profiles. Daniel Santos on the new board question — “What’s our exposure to AI-driven misconduct?” — and why AI accountability, not technology, decides whether your governance holds up under scrutiny.
Red Flag: The Vendor Requested Far More PHI Than the Service Required
A vendor deal that looked routine — clean MSA, sensible pricing, BAA already in place — almost moved forward in minutes. Then the SOW revealed a PHI request far beyond what was actually needed. Robyn D. Marino on why HIPAA compliance doesn’t stop at the BAA, and how SOW-level review changes the risk calculus on healthcare vendor agreements.
How One Clause Rewrite Protected Their Data and Future Growth
I worked with a client who nearly signed away something they hadn’t planned to give…
Health Tech Founders Don’t Need More Legal Warnings. They Need Better Thinking
Most content from law firms follows a predictable pattern: highlight a new regulation, point out…
Outsourcing vs. In-House: Finding the Right Balance to Maximize GC Productivity
In today’s high-pressure legal environment, especially in regulated sectors like health tech and digital health,…
Navigating Regulatory Hurdles in the Health Tech Industry
Technology is changing health care. As cited by a study from the National Institutes of…
A Comprehensive Guide to Mitigating Third Party Risks in Procurement
One of the keys to effective procurement is mitigating the risks posed by third parties….
